RSV Diagnostic Market

Global RSV Diagnostic Market is valued at USD 767.8 Million in 2020 and is expected to reach USD 1465.1 Million by 2027 with a CAGR of 9.67% over the forecast period.

Global Respiratory Syncytial Virus (RSV) Diagnostic Market: Global Size, Trends, Competitive, Historical Forecast Analysis, 2021-2027- Factors like increasing prevalence of respiratory diseases, growing demand of POC test kits, and increasing cases of the pneumonia-like disease in infants or in geriatric population driving the growth of the market.

Scope of Global Respiratory Syncytial Virus (RSV) Diagnostics Market:

The respiratory syncytial virus is a very common and contagious virus that infects the respiratory tract of most children before 1-2 years of their age. RSV was discovered from chimpanzees BY J. Morris and an associate in 1956. RSV is an enveloped RNA virus of the family Paramyxoviridae that causes lung infections. It affects all generations but it is very dangerous for infants and older infants. RSV is the most common cause of bronchiolitis and pneumonia. It also causes respiratory illness in adults and it can occasionally cause a serious infection that needs hospitalization from breathing compromise with bronchiolitis or pneumonia. In most people, symptoms usually develop after 4-6 days of exposure to RSV which is known as the incubation period of the RSV virus. Symptoms of RSV include runny nose, loss of appetite followed by coughing or sneezing, or mild fever. Also in infants sometimes develop serious symptoms like wheezing, irritability, cyanosis, and breathing difficulties. RSV spreads from person to person via coughing or sneezing. For diagnosis, most doctors use blood or urine test to look for a bacterial infection, a chest x-ray for checking any signs of pneumonia, a test of material scraped out from a person's nose or, mouth. In the treatment of RSV of infants, doctors use a cool-mist vaporizer to keep the air moist and make breathing easier. Also, nonaspirin fever reducer tablets are used. In serious cases, doctors use IV fluids or medications to open the airways.

Covid-19 has shown a positive impact on the growth of the global RSV diagnostics market owing to the increasing prevalence of Covid-19 cases which is also respiratory disease. And RSV is also a contagious respiratory infection. Thus, some of the players are offering and producing RSV diagnostic kits with a combination of Covid-19 testing. For example; on January 13^th, 2021; TCA/GENETWORx Labs has unveiled a diagnostic Flu A-B/COVID-19/RSV combination test that provides patients with early detection of all three separate respiratory viruses with just one test sample.

The regions covered in this Global RSV diagnostic market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of RSV diagnostic is subdivided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key players of Global Respiratory Syncytial Virus (RSV) Diagnostic Market:

Some major key players of global RSV diagnostics market are Becton, Dickinson and Company, Novartis diagnostics, Abbott laboratories, ortho clinical diagnostics, Thermo fisher scientific inc., Bio-rad laboratories inc., Hoffmann la Roche limited, Biomerieux, Diasorin spa, Emd millipore, Quidel corporation, Alere inc., Coris bioconcept, fast-track diagnostics, Quest diagnostics and others.

Global RSV Diagnostics Market Segmentation Analysis:

The global RSV diagnostic market is segmented on the basis of type, method, end-user, and regional & country level. On the basis of type, the market is classified into kits, instruments, and others. On the basis of method, the market is classified into molecular diagnostics and rapid antigen detection tests. On the basis of end-user, the market is classified into hospitals, clinics, clinical labs, and home care.

By Type:

• Kits
• Instruments
• Others

By Methods:

• Molecular Diagnostics 
• Rapid Antigen Detection Tests
• Enzyme-Linked Immunosorbent Assays
• Immunofluorescence Assays
• Other Rapid Antigen Detection Tests

By End-User:

• Hospitals, clinics
• Clinical labs
• Home care

News:

New All-in-One Test for COVID-19/Flu/RSV

On January 13th, 2021; TCA/GENETWORx Labs has unveiled a diagnostic Flu A-B/COVID-19/RSV combination test that provides patients with early detection of all three separate respiratory viruses with just one test sample. The TCA/GENETWORx Flu A-B/COVID Combo Test is a molecular diagnostic PCR test that detects two types of influenza viruses; influenza A and B and differentiates them from RSV, and SARS-CoV-2, the virus that causes COVID-19. The Flu A-B/COVID Combo Test provided by GENETWORx has a 98% accuracy rate for influenza, 99% for COVID-19, and 96% for RSV.

Increasing Prevalence of Respiratory Diseases and Rising Prevalence of Covid-19 Cases are the Major Factors Driving the Market Growth

The increasing prevalence of respiratory diseases, the growing demand for POC test kits, and increasing cases of the pneumonia-like disease in infants or in the geriatric population drive the growth of the market. For example; according to American Lung Association, infants have a high risk of developing RSV. About 5%-10% of infants are getting affected by RSV and 25%-40% of people having bronchitis and pneumonia have chances to develop RSV in them. This respiratory syncytial virus can pass from one person to another. It enters the body through the eyes, nose, or mouth. This virus can infect people by coughing or sneezing and also by shaking hands. In addition, the growing demand for POC tests for the diagnosis of RSV infections is also propelling the growth of the market. As the main feature of POC testing is rapidity. It provides immediate information to physicians about patients’ health conditions.

These tests are effective in case of RSV to check the infection. Therefore growing demand for POC tests for diagnosis is propelling the growth of the market. Furthermore, an increasing number of product offerings by key players is also fostering the market growth. For instance; in March 2020 Roche diagnostics launch the Cobas Liat POC device. This device shows excellent analytical performance to detect influenza A, influenza B, and RSV, and it is considered easy to use. Also, adults having chronic disorders or weak immune systems have a high risk of developing RSV. However, a lack of awareness among the parents about its diagnostics especially in rural areas may hamper the growth of the market. In spite of that, advancement in diagnostic technology can offer more opportunities for the further growth of the market.

Regional Analysis:

North America is Expected to Dominate the Global Respiratory Syncytial Virus (RSV) Diagnostics Market

The global RSV diagnostics market is segmented into North America, Europe, Asia-Pacific Latin America, and Middle East & Africa. North America is expected to dominate the global RSV diagnostics market within the forecast period due to increasing cases of RSV infection in this region. For instance; According to CDC (Centre for Disease Control and Prevention) it is estimated that more than 177,000 older adults are hospitalized and 14000 of them die in the US due to RSV infection. In addition, an increasing number of product offerings by leading players is also fostering the market growth. For example; in 2020 Bio-Rad launched SARS-CoV-2, RSV positive and negative run controls for respiratory PCR assays in which SARS-CoV-2, RSV positive run control is made with whole organism SARS-COV2, influenza A, influenza B, and RSV. This product is made with a synthetic matrix and the human genome.

Europe is projected to capture the significant share of the global RSV market attributed to an increase in the adoption of POC tests and rising cases of chronic respiratory diseases such as RSV in this region. For example; according to WHO it is estimated that 65 million people affected by moderate to severe chronic respiratory disease, from which 3 million people die each year.

Report Analysis	Details
Historical data	2015 - 2020
Forecast Period	2021 - 2027
Market Size in 2020:	USD 767.8 Million
Base year considered	2020
Forecast Period CAGR %:	9.67 %
Market Size Expected in 2027:	USD 1465.1 Million
Tables, Charts & Figures:	175
Pages	200
Key Players/Companies	Becton, Dickinson and Company, Novartis diagnostics, Abbott laboratories, ortho clinical diagnostics, Thermo fisher scientific inc., Bio-rad laboratories inc., Hoffmann la Roche limited, Biomerieux, Diasorin spa, Emd millipore, Quidel Corporation, Alere inc., Coris bio concept, fast-track diagnostics, Quest diagnostics, and others
Segments Covered	By Type, By End-User, By Methods
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits of Global Respiratory Syncytial Virus (RSV) Diagnostics Market:

• Global RSV Diagnostics Market report covers in-depth historical and forecast analysis.
• Global RSV Diagnostics Market research report provides detailed information about Market Introduction, Market Summary, Global market, Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global RSV Diagnostics Market report helps to identify opportunities in
• Global RSV Diagnostics Market report covers an extensive analysis of emerging trends and competition.

On Special Requirement Respiratory Syncytial Virus (RSV) Diagnostics Market Report is also available for the below Regions and Country:

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA